rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-7-18
|
pubmed:abstractText |
In Western countries, only a small proportion of patients with hepatocellular carcinoma (HCC) can be treated with surgical resection. For other patients, locoregional management by transcatheter oily chemoembolization seems to be useful and warrants evaluation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16-24
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7516263-Aged,
pubmed-meshheading:7516263-Antineoplastic Agents,
pubmed-meshheading:7516263-Carcinoma, Hepatocellular,
pubmed-meshheading:7516263-Cause of Death,
pubmed-meshheading:7516263-Chemoembolization, Therapeutic,
pubmed-meshheading:7516263-Cisplatin,
pubmed-meshheading:7516263-Doxorubicin,
pubmed-meshheading:7516263-Epirubicin,
pubmed-meshheading:7516263-Female,
pubmed-meshheading:7516263-France,
pubmed-meshheading:7516263-Hepatic Artery,
pubmed-meshheading:7516263-Humans,
pubmed-meshheading:7516263-Iodized Oil,
pubmed-meshheading:7516263-Liver Neoplasms,
pubmed-meshheading:7516263-Male,
pubmed-meshheading:7516263-Middle Aged,
pubmed-meshheading:7516263-Survival Rate,
pubmed-meshheading:7516263-alpha-Fetoproteins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients.
|
pubmed:affiliation |
Services d'Hépatogastroentérologie et de Chirurgie, Centre Hospitalier Universitaire, Strasbourg, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Multicenter Study
|